IGLV2-14 light chain sequences of patients with AL amyloidosis or multiple myeloma. IGLV2-14 light chain sequences of patients with AL amyloidosis or multiple myeloma

Light chain (AL) amyloidosis is one of the most common forms of systemic amyloidosis and is caused by the deposition of insoluble fibrils derived from misfolded and aggregated immunoglobulin light chains (LC). To uncover the causes leading to this aggregation, we compared AL LC sequences with those of patients with the related disease multiple myeloma (MM), which do not aggregate in insoluble fibrils in vivo. IGLV2-14 is one of the most common AL associated IGLV-subfamilies. Here we analyzed IGLV2-14 LC sequences of 13 AL and eight MM patients in detail. We found that AL associated LCs presented a lower median mutation count (7.0 vs. 11.5 in MM; p= 0.045) as well as an overall composition of less charged amino acids than MM LCs – but, we did not find a mutation that was present in ≥50 % of the AL and not in the MM sequences. We also did not find a significant difference in the isoelectric point (pI) in general, suggesting similar stability of the LCs in AL and MM. However, the subgroup of patients without a detectable heavy chain stood out. Surprisingly, they are characterized by an increase in mutation count (median 7.0 vs. 5.5) and pI (median 7.82 vs. 6.44, p= 0.043). In conclusion, our data suggest that the amount of mutations and the introduction of charges could play a crucial role in AL fibril formation as well as the absence or presence of a potential heavy chain binding partner.